Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-05-17FDA Approved: AIMOVIG — Original Application (Amgen Inc)
FDA approved AIMOVIG (erenumab) from Amgen as an original application for the preventive treatment of migraine in adults. This marks the ini…
-
FDA approval · 2018-03-06FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie, authorizing changes to its labeling.
-
FDA approval · 2018-02-15FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for a generic sumatriptan and naproxen sodium combination tablet for the acute treatment of migraine.
-
FDA approval · 2018-01-03FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
FDA approved a supplemental application for TROKENDI XR (topiramate) from Supernus Pharmaceuticals, expanding the labeling of the extended-r…
-
FDA approval · 2018-01-02FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Excedrin Migraine GelTabs, a combination of acetaminophen, aspirin, and caffeine, from Haleon US…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-27FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (Dr. Reddy's Labratories Inc.)
FDA approved the original ANDA for a generic butalbital and acetaminophen combination manufactured by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2017-12-14FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for IMITREX (sumatriptan) from GlaxoSmithKline LLC to modify the product labeling.
-
FDA approval · 2017-12-14FDA Approved: SUMATRIPTAN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Sumatriptan submitted by Prasco Laboratories.
-
FDA approval · 2017-12-14FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Imitrex (sumatriptan) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2017-11-24FDA Approved: TOPIRAMATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original generic application for Topiramate from Zydus Lifesciences Limited, enabling a generic version to reach the market…
-
FDA approval · 2017-10-12FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Excedrin Migraine GelTabs (acetaminophen, aspirin, caffeine) from Haleon US Holdings LLC.
-
FDA approval · 2017-09-15FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves an original ANDA for dihydroergotamine mesylate from Hikma Pharmaceuticals USA Inc., enabling generic availability for migraine…
-
FDA approval · 2017-09-13FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Excedrin Migraine Geltabs from Haleon US Holdings LLC.
-
FDA approval · 2017-08-11FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Eletriptan hydrobromide as an original application, authorizing a generic version of eletriptan for the acute treatment of …
-
FDA approval · 2017-06-27FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's Eletriptan Hydrobromide as an original generic application (ANDA) for the acute treatment of migraine with or without au…
-
FDA approval · 2017-06-16FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for Eletriptan hydrobromide from Zydus Pharmaceuticals USA Inc., establishing a generic option for the…
-
FDA approval · 2017-03-29FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Topiramate submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2017-03-20FDA Approved: ZEMBRACE SYMTOUCH — Supplemental Application (Upsher-Smith laboratories, LLC)
FDA supplemental approval for ZEMBRACE SYMTOUCH (sumatriptan succinate) submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2017-03-07FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved an original generic application for rizatriptan benzoate (Unichem Pharmaceuticals USA) for the acute treatment of migraine.
-
FDA approval · 2017-03-07FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Unichem Pharmaceuticals (USA), Inc.'s Rizatriptan Benzoate as an original application (ANDA 207835), a generic product for the …
-
FDA approval · 2017-03-06FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approves a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, authorizing changes to the product labeling …
-
FDA approval · 2017-02-27FDA Approved: ZOMIG — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's original application for zolmitriptan (generic) for the acute treatment of migraine, expanding access to a generic for…
-
FDA approval · 2017-01-11FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Panacea Biotec Limited)
FDA approves Panacea Biotec Limited's rizatriptan benzoate Original Application (ANDA) for the acute treatment of migraine, adding a generic…
-
FDA approval · 2017-01-06FDA Approved: TOPIRAMATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' supplemental application for Topiramate Sprinkle, a generic version of topiramate. The product is man…
-
FDA approval · 2016-12-01FDA Approved: ZOLMITRIPTAN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original ANDA for zolmitriptan tablets, providing a generic option for the acute treatment of migraine…